Omnimmune Holdings Inc. (OMMH) Financials Oct 22,
Post# of 250675
Posted On: 11/17/2014 2:21:17 AM
Omnimmune Holdings Inc. (OMMH) Financials Oct 22, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Omnimmune Holdings Inc.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 0 0
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - - - - 0
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income - 0 0 0 0
2006 2007 2008 2009 5-year trend
SG&A Expense - 667,348 875,794 5.48M 1.52M
Research & Development - - - - 0
Other SG&A - 667,348 875,794 5.48M 1.52M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 1.2M (5.69M) 0
EBIT after Unusual Expense - 0 (1.2M) 5.69M 0
Non Operating Income/Expense - 0 0 619,503 0
Non-Operating Interest Income - 0 0 386 0
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 408,918 694,553 6.82M 239,208
Gross Interest Expense - 408,918 694,553 6.82M 239,208
Interest Capitalized - 0 0 0 0
Pretax Income - (1.08M) (2.77M) (5.99M) (1.76M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - 0
Equity in Affiliates - - - - -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (1.08M) (2.77M) (5.99M) (1.76M)
Minority Interest Expense - 0 0 0 0
Net Income - (1.08M) (2.77M) (5.99M) (1.76M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - - - - -
Discontinued Operations - - - - 0
Net Income After Extraordinaries - (1.08M) (2.77M) (5.99M) (1.76M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1.08M) (2.77M) (5.99M) (1.76M)
EPS (Basic) - (0.14) (0.35) (1.00) (0.20)
Basic Shares Outstanding - 7.78M 7.9M 6.01M 8.84M
EPS (Diluted) - (0.14) (0.35) (1.00) (0.20)
Diluted Shares Outstanding - 7.78M 7.9M 6.01M 8.84M
EBITDA - - - - (1.52M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Omnimmune Holdings Inc.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 0 0
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - - - - 0
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income - 0 0 0 0
2006 2007 2008 2009 5-year trend
SG&A Expense - 667,348 875,794 5.48M 1.52M
Research & Development - - - - 0
Other SG&A - 667,348 875,794 5.48M 1.52M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 1.2M (5.69M) 0
EBIT after Unusual Expense - 0 (1.2M) 5.69M 0
Non Operating Income/Expense - 0 0 619,503 0
Non-Operating Interest Income - 0 0 386 0
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 408,918 694,553 6.82M 239,208
Gross Interest Expense - 408,918 694,553 6.82M 239,208
Interest Capitalized - 0 0 0 0
Pretax Income - (1.08M) (2.77M) (5.99M) (1.76M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - 0
Equity in Affiliates - - - - -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (1.08M) (2.77M) (5.99M) (1.76M)
Minority Interest Expense - 0 0 0 0
Net Income - (1.08M) (2.77M) (5.99M) (1.76M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - - - - -
Discontinued Operations - - - - 0
Net Income After Extraordinaries - (1.08M) (2.77M) (5.99M) (1.76M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1.08M) (2.77M) (5.99M) (1.76M)
EPS (Basic) - (0.14) (0.35) (1.00) (0.20)
Basic Shares Outstanding - 7.78M 7.9M 6.01M 8.84M
EPS (Diluted) - (0.14) (0.35) (1.00) (0.20)
Diluted Shares Outstanding - 7.78M 7.9M 6.01M 8.84M
EBITDA - - - - (1.52M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)